Patent ID: 9644021
Date: 2017-05-09
CPC Classifications: C07K

Claim:
1. An antibody fusion comprising: (a) a first antibody sequence; (b) at least a portion of an ultralong complementarity determining region 3 (CDR3), wherein the portion of the ultralong CDR3 is 15 amino acids to 61 amino acids long; and (c) a non-antibody sequence, wherein the non-antibody sequence is selected from a polypeptide selected from a group consisting of a Mamba1, a oxyntomodulin, a 550 peptide, an Amgen 1, and a parathyroid hormone; wherein the portion of the ultralong CDR3 is fused or inserted into a hypervariable region of the first antibody sequence, and wherein the non-antibody sequence is fused or inserted into the portion of the ultralong CDR3.